TY - JOUR
T1 - Motivational tools to improve probationer treatment outcomes
AU - Taxman, Faye S.
AU - Walters, Scott T.
AU - Sloas, Lincoln B.
AU - Lerch, Jennifer
AU - Rodriguez, Mayra
N1 - Funding Information:
Research reported in this publication was supported by National Institute on Drug Abuse, National Institutes of Health under award number R01 DA029010 (Walters, Taxman). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2015 Published by Elsevier Inc.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Background: Motivational interviewing (MI) is a promising practice to increase motivation, treatment retention, and reducing recidivism among offender populations. Computer-delivered interventions have grown in popularity as a way to change behaviors associated with drug and alcohol use. Methods/Design: Motivational Assistance Program to Initiate Treatment (MAPIT) is a three arm, multisite, randomized controlled trial, which examines the impact of Motivational interviewing (MI), a motivational computer program (MC), and supervision as usual (SAU) on addiction treatment initiation, engagement, and retention. Secondary outcomes include drug/alcohol use, probation progress, recidivism (i.e., criminal behavior) and HIV/AIDS testing and treatment among probationers. Participant characteristics are measured at baseline, 2, and 6. months after assignment. The entire study will include 600 offenders, with each site recruiting 300 offenders (Baltimore City, Maryland and Dallas, Texas). All participants will go through standard intake procedures for probation and participate in probation requirements as usual. After standard intake, participants will be recruited and screened for eligibility. Discussion: The results of this clinical trial will fill a gap in knowledge about ways to motivate probationers to participate in addiction treatment and HIV care. This randomized clinical trial is innovative in the way it examines the use of in-person vs. technological approaches to improve probationer success. Trial registration: NCT01891656.
AB - Background: Motivational interviewing (MI) is a promising practice to increase motivation, treatment retention, and reducing recidivism among offender populations. Computer-delivered interventions have grown in popularity as a way to change behaviors associated with drug and alcohol use. Methods/Design: Motivational Assistance Program to Initiate Treatment (MAPIT) is a three arm, multisite, randomized controlled trial, which examines the impact of Motivational interviewing (MI), a motivational computer program (MC), and supervision as usual (SAU) on addiction treatment initiation, engagement, and retention. Secondary outcomes include drug/alcohol use, probation progress, recidivism (i.e., criminal behavior) and HIV/AIDS testing and treatment among probationers. Participant characteristics are measured at baseline, 2, and 6. months after assignment. The entire study will include 600 offenders, with each site recruiting 300 offenders (Baltimore City, Maryland and Dallas, Texas). All participants will go through standard intake procedures for probation and participate in probation requirements as usual. After standard intake, participants will be recruited and screened for eligibility. Discussion: The results of this clinical trial will fill a gap in knowledge about ways to motivate probationers to participate in addiction treatment and HIV care. This randomized clinical trial is innovative in the way it examines the use of in-person vs. technological approaches to improve probationer success. Trial registration: NCT01891656.
KW - Computer-delivered interventions
KW - Criminal behavior
KW - E-Health
KW - HIV risk
KW - MAPIT
KW - Motivational interviewing
KW - Substance use
UR - http://www.scopus.com/inward/record.url?scp=84930933225&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2015.05.016
DO - 10.1016/j.cct.2015.05.016
M3 - Article
C2 - 26009023
AN - SCOPUS:84930933225
SN - 1551-7144
VL - 43
SP - 120
EP - 128
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
ER -